The global antiviral oral liquid market surpassed USD 3,781 million in 2024 and is projected to reach about USD 5,181 million by 2034, expanding at a CAGR of 3.2%. Growth is driven by rising viral infection cases and improved liquid formulation therapies.
Antiviral Oral Liquid Market Statical Scope
| Reports Attributes | Statistics |
| Market Size in 2024 | USD 3,781 Million |
| Market Size in 2025 | USD 3,902 Million |
| Market Size in 2031 | USD 4,714 Million |
| Market Size by 2034 | USD 5,181 Million |
| CAGR 2025 to 2034 | 3.20% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
What is Medical Oral Nutrition Supplements Market Size in 2024 to 2034?
The global medical oral nutrition supplements market was valued at USD 7,745 million in 2024 and is projected to reach USD 11,031 million by 2034, growing at a CAGR of 3.6%. Growth is driven by rising malnutrition cases and increasing geriatric population.
What is Pet Oral Care Products Market Size in 2024 to 2034?
The global pet oral care products market was valued at USD 3.2 billion in 2024 and is expected to reach USD 5.57 billion by 2034, growing at a 5.7% CAGR, driven by rising pet ownership and increased focus on companion animal dental health
Antiviral Oral Liquid Market Companies:
- Pfizer
- Roche
- Novartis
- Merck
- GlaxoSmithKline
- Johnson & Johnson
- AbbVie
- Sanofi
- Bristol-Myers Squibb
- AstraZeneca
- Eli Lilly
- Novo Nordisk
- Amgen
- Gilead Sciences
- CSL
- Takeda Pharmaceuticals
- Bayer
- Celgene
- Merck KGaA
- Allergan
Antiviral Oral Liquid Market Segmentation:
By Type
- Syrup
- Oral suspension
- Oral solution
- Oral drop
- Oral emulsion
- Mixture
By Application
- Adults
- Children
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Global Market Size
Antiviral Oral Liquid Market Size By Region 2025 to 2034 (USD Million)
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
| North America | 1,323.35 | 1,357.89 | 1,393.29 | 1,429.57 | 1,466.74 | 1,504.82 | 1,543.84 | 1,583.81 | 1,624.77 | 1,666.72 | 1,709.69 |
| Asia Pacific | 1,134.30 | 1,186.21 | 1,240.27 | 1,296.58 | 1,355.23 | 1,416.30 | 1,479.89 | 1,546.10 | 1,615.04 | 1,686.80 | 1,761.50 |
| Europe | 756.20 | 772.59 | 789.26 | 806.21 | 823.43 | 840.93 | 858.70 | 876.75 | 895.08 | 913.68 | 932.56 |
| LAMEA | 567.15 | 585.30 | 604.03 | 623.36 | 643.31 | 663.89 | 685.14 | 707.06 | 729.69 | 753.04 | 777.13 |
Antiviral Oral Liquid Market Size By Type 2025 to 2034 (USD Million)
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
| Syrup | 1,134.30 | 1,158.89 | 1,183.90 | 1,209.31 | 1,235.15 | 1,261.39 | 1,288.05 | 1,315.13 | 1,342.62 | 1,370.52 | 1,398.84 |
| Oral suspension | 756.20 | 788.20 | 821.48 | 856.08 | 892.05 | 929.45 | 968.32 | 1,008.74 | 1,050.75 | 1,094.41 | 1,139.79 |
| Oral solution | 567.15 | 593.10 | 620.14 | 648.29 | 677.61 | 708.15 | 739.95 | 773.05 | 807.52 | 843.40 | 880.75 |
| Oral drop | 378.10 | 394.10 | 410.74 | 428.04 | 446.03 | 464.72 | 484.16 | 504.37 | 525.37 | 547.21 | 569.90 |
| Oral emulsion | 302.48 | 316.06 | 330.20 | 344.92 | 360.25 | 376.21 | 392.81 | 410.09 | 428.08 | 446.80 | 466.28 |
| Mixture | 642.77 | 651.63 | 660.40 | 669.07 | 677.61 | 686.02 | 694.27 | 702.35 | 710.23 | 717.89 | 725.32 |
Antiviral Oral Liquid Market Size By Application 2025 to 2034 (USD Million)
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
| Adults | 2,646.70 | 2,715.79 | 2,786.58 | 2,859.13 | 2,933.47 | 3,009.64 | 3,087.68 | 3,167.63 | 3,249.53 | 3,333.44 | 3,419.38 |
| Children | 1,134.30 | 1,186.21 | 1,240.27 | 1,296.58 | 1,355.23 | 1,416.30 | 1,479.89 | 1,546.10 | 1,615.04 | 1,686.80 | 1,761.50 |
List of Table and Figure
List of Tables
- Table 1: North America Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 2: North America Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 3: U.S. Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 4: U.S. Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 5: Canada Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 6: Canada Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 7: Mexico Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 8: Mexico Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 9: Europe Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 10: Europe Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 11: Germany Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 12: Germany Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 13: U.K. Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 14: U.K. Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 15: France Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 16: France Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 17: Italy Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 18: Italy Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 19: Rest of Europe Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 20: Rest of Europe Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 21: Asia-Pacific Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 22: Asia-Pacific Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 23: China Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 24: China Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 25: Japan Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 26: Japan Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 27: India Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 28: India Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 29: South Korea Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 30: South Korea Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 31: Southeast Asia Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 32: Southeast Asia Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 33: Latin America Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 34: Latin America Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 35: Brazil Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 36: Brazil Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 37: Rest of Latin America Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 38: Rest of Latin America Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 39: Middle East & Africa Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 40: Middle East & Africa Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 41: GCC Countries Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 42: GCC Countries Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 43: Turkey Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 44: Turkey Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
- Table 45: Africa Antiviral Oral Liquid Market Size, by Type, 2024–2034 (USD Million)
- Table 46: Africa Antiviral Oral Liquid Market Size, by Application, 2024–2034 (USD Million)
List of Figures
- Figure 1: Antiviral Oral Liquid Market Share, by Type, 2024 (%)
- Figure 2: Antiviral Oral Liquid Market Share, by Application, 2024 (%)
- Figure 3: Global Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 4: North America Antiviral Oral Liquid Market Share, by Country, 2024 (%)
- Figure 5: Europe Antiviral Oral Liquid Market Share, by Country, 2024 (%)
- Figure 6: Asia-Pacific Antiviral Oral Liquid Market Share, by Country, 2024 (%)
- Figure 7: Latin America Antiviral Oral Liquid Market Share, by Country, 2024 (%)
- Figure 8: Middle East & Africa Antiviral Oral Liquid Market Share, by Country, 2024 (%)
- Figure 9: U.S. Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 10: Canada Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 11: Mexico Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 12: Germany Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 13: U.K. Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 14: France Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 15: Italy Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 16: China Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 17: Japan Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 18: India Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 19: South Korea Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 20: Brazil Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 21: GCC Countries Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 22: South Africa Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 23: Turkey Antiviral Oral Liquid Market Forecast, 2024–2034 (USD Million)
- Figure 24: Global Antiviral Oral Liquid Competitive Landscape, 2024 (%)
Principal Research Analyst | Towards Dental
Rohan Patil stands at the forefront of dental market research, leveraging over five years of specialized experience to navigate the intricate landscape of the global dental industry. As Principal Research Analyst at Towards Dental, he spearheads comprehensive research initiatives that encompass a broad spectrum of dental sectors, including orthodontics, periodontics, prosthodontics, and endodontics.
At Towards Dental, Rohan's expertise extends to analyzing emerging trends in dental technologies, regulatory frameworks, and market dynamics. He is instrumental in assessing the adoption of digital dentistry, advancements in dental materials, and the integration of artificial intelligence in diagnostic and treatment modalities.
Rohan's analytical acumen is complemented by his proficiency in translating complex data into actionable insights, enabling him to provide strategic recommendations that inform decision-making across the dental industry. His work not only supports dental professionals and organizations but also contributes to shaping the future trajectory of dental care globally. A trusted advisor and relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving dental landscape.
Rohan Patil stands at the forefront of dental market research, leveraging over five years of specialized experience to navigate the intricate landscape of the global dental industry. As Principal Research Analyst at Towards Dental, he spearheads comprehensive research initiatives that encompass a broad spectrum of dental sectors, including orthodontics, periodontics, prosthodontics, and endodontics.
At Towards Dental, Rohan's expertise extends to analyzing emerging trends in dental technologies, regulatory frameworks, and market dynamics. He is instrumental in assessing the adoption of digital dentistry, advancements in dental materials, and the integration of artificial intelligence in diagnostic and treatment modalities.
Rohan's analytical acumen is complemented by his proficiency in translating complex data into actionable insights, enabling him to provide strategic recommendations that inform decision-making across the dental industry. His work not only supports dental professionals and organizations but also contributes to shaping the future trajectory of dental care globally. A trusted advisor and relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving dental landscape.
Latest posts by Rohan Patil (see all)
- Mobile Dental Unit Market Size to Attain USD 3.76 Billion by 2034 - January 6, 2026
- Dental Cone Beam CT Market Size to Attain USD 1,247.49 Million by 2034 - January 5, 2026
- Dental Resins Market Size to Lead USD 2.7 Billion by 2034 - January 2, 2026
Author
